Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2015

View Archived Issues

Otonomy submits NDA to the FDA for AuriPro

Abivax recruits first patient in pivotal phase IIb/III trial of ABX-203

ReveraGen awarded grant to fun development of VBP-15 for Duchenne muscular dystrophy

Rosetta Genomics updates development progress of microRNA-based thyroid neoplasia assay

Phase II trial initiated of Aduro Biotech's GVAX Pancreas and CRS-207 in combination with nivolumab

Amarin and Eddingpharm sign Vascepa agreement for China

Bovine lactoferrin receives two FDA orphan designations

Triphase Accelerator and Sunnybrook Research Institute to collaborate on TRPH-011

Merck Patent discloses new fatty acid synthase inhibitors

German organization patents GRK5 modulators

Gruenenthal patent reports new CRAC inhibitors

New MEK inhibitors patented by Novartis

Scientists at ICGEB disclose anti-dengue virus vaccine

Lenvima now available in U.S.

Inhibition of HIV RNA biogenesis blocks viral replication and avoids viremia rebound

CHMP recommends conditional marketing approval of ceritinib

EMA's CHMP backs approval of Jinarc for rare kidney disease

EMA committee recommends new approval of Vectibix in metastatic colorectal cancer

FDA postpones meeting to discuss a BLA for Celltrion's CT-P13

Combination therapy shows efficiency for HIV/HCV coinfection treatment

Takeda withdraws new European Rienso submission

ENDEAVOR trial shows superiority of Kyprolis over Velcade in relapsed multiple myeloma

EMA accepts MAA for Santen's intravitreal sirolimus for non-infectious uveitis

Ibalizumab receives FDA breakthrough therapy designation

Rare Disease Day 2015: Focus on new means of developing treatments

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...